Emerging Applications of Synthetic Biology in Diagnostics

Published: November 2025

Over the last decade, the biotechnology market has witnessed a steady influx of novel diagnostic tools and emerged as one of the most promising segments of the healthcare industry. Ongoing innovation and extensive research efforts in this domain have led to the development and commercialization of several novel detection platforms.

Synthetic biology tools, such as engineered biosensors, enable identification of biomarkers in clinical settings, and are convenient and easy to use. These biosensors are genetically programmed systems working on various mechanisms (ranging from simple cell-free reactions to fully integrated cellular circuits) and include pre-designed genetic elements, which eliminates the need to build detection assays from scratch, thus resolving various diagnostic-related accuracy issues faced by clinicians. Further, the real-time reporting features in some of the biosensors allow users to monitor signals instantly when detection is completed. These tools enable the identification of diseases through different sample types in an efficient and relatively simple manner.

With the growing adoption of engineered biological systems and ongoing advancements in the technologies (focused on modular genetic circuits, CRISPR integration and real-time data logging), the global synthetic biology diagnostics market is likely to grow, in the foreseen future.

Roots Analysis has conducted an exhaustive study on Synthetic Biology in Healthcare Market featuring the current market landscape and future opportunity for the companies engaged in providing synthetic biology products and services, over a span of 10 years. In this article, we have highlighted some of the emerging applications of synthetic biology in diagnostics that are likely to shape the evolution of diagnostics market.

Application of Synthetic Biology

Want to explore the latest advancements in synthetic biology application??

Emerging Applications of Synthetic Biology in Diagnostics that Are Likely to Shape the Synthetic Biology Market

CRISPR-Based Tools: Revolutionizing Molecular Diagnostics
CRISPR-based systems facilitate rapid nucleic acid detection, rendering them appropriate for point-of-care testing. These tools amplify signals from pathogens or biomarkers and provide visual readouts, improving accuracy in disease identification and enhancing clinical outcomes. Further, in September 2025, VedaBio partnered with Mammoth Biosciences in a non-exclusive licensing deal to incorporate CRISPR intellectual property into amplification-free molecular detection platforms, accelerating customized diagnostics for clinical use and enhancing precision in biomarker identification.
Synthetic Gene Circuits: Enhancing Diagnostic Precision
Synthetic gene circuits are engineered to detect specific biomarkers with high specificity, enabling early diagnosis of diseases like cancer and infectious diseases. These circuits integrate multiple genetic components to create robust diagnostic responses, offering improved sensitivity over traditional methods. In August 2025, a review highlighted advancements in engineered living materials incorporating synthetic gene circuits for biosensing, enabling autonomous detection of environmental and pathological signals in medical diagnostics, such as real-time monitoring of disease biomarkers in biomedicine.
Metabolic Biosensors: Pioneering Real-Time Monitoring
Metabolic biosensors, designed using synthetic biology, enable real-time monitoring of physiological changes, such as glucose or lactate levels, for chronic disease management. These biosensors are tailored for wearable devices, providing continuous data to clinicians. Companies like Synlogic have invested heavily in developing such biosensors for metabolic disorders.
Paper-Based Diagnostics: Expanding Access to Low-Resource Settings
Paper-based synthetic biology diagnostics, leveraging cell-free systems, offer a cost-effective and portable solution for disease detection in low-resource settings. These platforms use freeze-dried genetic components to detect pathogens like Zika or Ebola, requiring minimal equipment. Additionally, freeze-dried cell-free (FD-CF) systems can be stored at room temperature and later activated with just water, making them especially suited for areas lacking refrigeration and specialized logistics. These diagnostics have demonstrated the ability to detect targets at clinically relevant concentrations, with applications extending from infectious disease outbreaks to broader global health initiatives.
Synthetic Biology for Multiplexed Diagnostics: Detecting Multiple Pathogens
Multiplexed diagnostic systems, powered by synthetic biology, allow simultaneous detection of multiple biomarkers or pathogens in a single assay. These systems integrate engineered genetic circuits to provide comprehensive diagnostic profiles, enhancing efficiency in clinical settings. In 2025, research highlighted the emergence of wearable multiplexed diagnostic biosensors using synthetic gene circuits and RNA regulators, delivering real-time pathogen detection with minimal infrastructure needs. Recent studies also reported fast, versatile assays employing multiplexed DNA barcoding, enabling simultaneous and sensitive identification of multiple targets in complex clinical samples.

Conclusion

The five emerging applications of synthetic biology in diagnostics are in line with the growing trends towards point-of-care and personalized testing. Over the years, synthetic biology tools have demonstrated significant potential as the next generation of patient-centric platforms, capable of safe and reliable detection of diseases. The growing awareness among clinical groups across the globe has encouraged them to adopt biosensors over traditional assays. Further, the advent of novel threats is driving the demand for detection of diverse biomarkers on larger scales. Consequently, many developers, such as the Wyss Institute and Broad Institute, have introduced advanced biosensors.

Given the increasing demand for diagnostic devices, there is a need within the healthcare industry to provide customization and additional enhancements in their platforms for product differentiation. This has led developers to incorporate feedback features in their systems, allowing them to gain insights from detection users for designing new and updated versions of biosensors with advanced features.

It is worth noting that the new synthetic biology devices, which are currently under development, are capable of addressing the specific needs and wants of individual clinicians. These are designed to enable adjustments in the sensitivity or features of the platform based upon the requirements of the user. Further, connecting the biosensors digitally to various products and platforms is expected to improve accuracy and quality of life for patients. Such connected diagnostic products are aimed at combining information for all conditions and lifestyles of the patients to improve healthcare outcomes.

Considering the rise in infectious diseases, along with fast-paced innovation in detection devices, the demand for engineered tools, such as biosensors, is likely to increase in the foreseen future.

Browse our full report on Synthetic Biology in Healthcare Market: https://www.rootsanalysis.com/reports/synthetic-biology-in-healthcare-market.html

Sources: